Affinivax
ID: 5331903Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
3
Funding Rounds
$348.5m
Money raised
Recent Funding Rounds
Overview
Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
- Website:
- Business model: B2B
- Headquarters: Cambridge, Massachusetts
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka**** Ta****** | - | - | - |
| Fa* Zh**** Ph* | - | - | - |
| Ri***** Ma***** MD | - | - | - |
| Yi***** Lu* Ph* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Affinivax has raised a total of $122.5m in funding over 3 rounds.
Key Insights:
- Affinivax Series B round, April 2020: $120m
- Affinivax Series A round, February 2016: $2.5m
- Affinivax, Inc. funding round, January 2021: $226m
Industries
Affinivax is active in the following industries: